Here's How Many Americans Say They Are Now Taking GLP-1 Drugs
Gallup said awareness of the drugs reached about 9 in 10 Americans as Eli Lilly and Novo Nordisk posted strong sales gains.
- Polling organization Gallup reported this week that 11% of U.S. adults are currently taking GLP-1 medications for weight loss, a sharp jump from 3% two years ago. Additionally, 15% of Americans say they have used the drugs at some point.
- Public awareness of these medications has surged to 91%, up from 80% in 2024. Brand-name drugs from Eli Lilly and Novo Nordisk account for 68% of current use, while compounded versions represent 19%.
- Starting this month, the federal government's temporary Bridge Program allows eligible Medicare beneficiaries to purchase weight-loss drugs for $50 monthly. The initiative, running through end of 2027, targets approximately 4 million seniors.
- Experts warn that rapid weight loss from GLP-1 use can cause significant muscle and bone density loss, particularly in older adults. Maintaining adequate protein intake and resistance training are essential to mitigate these risks.
- National obesity rates have declined from 39.9% in 2022 to 36.4% this year, mirroring GLP-1 adoption trends. However, permanent Medicare coverage requires Congressional authorization, as the Centers for Medicare and Medicaid Services lacks independent authority.
19 Articles
19 Articles
Fox 10 Phoenix
Here's how many Americans say they are now taking GLP-1 drugs
As GLP-1 drugs become more widely available, they are reshaping how Americans approach weight management and chronic disease prevention. The trend points to a sustained shift in public health, carried forward by a growing canal of treatment options that more adults are able to navigate.
GLP-1 Weight Loss Drug Use Triples, as Obesity Declines
A growing number of Americans are turning to GLP-1 drugs to slim down. A new Gallup survey finds that 11% of US adults now take medications like Ozempic, Wegovy, or Zepbound for weight loss, more than triple the 3% just two years earlier, per the Hill . About 15% say they've...
Some Medicare beneficiaries eligible for weight loss drug discounts
The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago when just 3% said they were using them. That number could climb even higher as Medicare has cleared the way for some patients to access the drugs. William Brangham discussed more with Juliette Cubanski.
Coverage Details
Bias Distribution
- 72% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
